Literature DB >> 9487366

[One hundred years of radiotherapy. Historical origins and development of fractionated irradiation in German speaking countries].

H Willers1, H P Heilmann, H P Beck-Bornholdt.   

Abstract

This review studies the historical development of fractionated X-ray therapy in the German speaking countries until World War II. Fractionated treatments appear to have their origin already in the first attempts of fractionation performed by Freund in 1896. In the following, fractionated treatments could not compete with the so-called single dose or intensive radiation treatment in Germany. However, until the 1920s there were repeated sporadic attempts of various motifs to distribute the radiation doses over a prolonged period of time. Only with the end of the 1920s the conditions for a rise of fractionated irradiation were favourable, mainly due the fiasco of the intensive treatments and their subsequent decline. The impulse for this rise, however, came from France where Coutard had developed an individual empirical treatment regimen with great clinical success. This technique and its modifications and developments spread over Europe and America fast. In spite of the similarities between the various fractionation methods used during the first decades of the century, review of the radiological literature of that time fails to show any logical scientific connection of these methods, but rather there was a mix and overlap of irradiation attempts of various motivations. Thus, radiation therapy, and thereby the current standard fractionation scheme of 1.8 to 2 Gy per fraction 5 times per week, obviously did not grow out of a scientific basis, but originated from individual observation of patients and empirical experience.

Entities:  

Mesh:

Year:  1998        PMID: 9487366     DOI: 10.1007/BF03038475

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  11 in total

1.  The history and evolution of radiotherapy and radiation oncology in Austria.

Authors:  H D Kogelnik
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-05-01       Impact factor: 7.038

2.  Radiation oncology: historical development in Germany.

Authors:  H P Heilmann
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-05-01       Impact factor: 7.038

3.  Regaud lecture perspectives on the history of radiotherapy.

Authors:  G H Fletcher
Journal:  Radiother Oncol       Date:  1988-08       Impact factor: 6.280

4.  Ralston Paterson.

Authors:  J A del Regato
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-07       Impact factor: 7.038

5.  Multiple fractions per day in retrospect; the L-Q model and the tolerance profile.

Authors:  H S Reinhold; A G Visser
Journal:  Radiother Oncol       Date:  1986-03       Impact factor: 6.280

6.  History of irradiation in squamous cell carcinomas of the larynx and hypopharynx.

Authors:  G H Fletcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-11       Impact factor: 7.038

7.  Henri Coutard.

Authors:  J A del Regato
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-03       Impact factor: 7.038

8.  Origins of radiotherapy and radiobiology: separation of the influence of dose per fraction and overall treatment time on normal tissue damage by Reisner and Miescher in the 1930s.

Authors:  H Willers; H P Beck-Bornholdt
Journal:  Radiother Oncol       Date:  1996-02       Impact factor: 6.280

9.  Claudius Regaud.

Authors:  J A Del Regato
Journal:  Int J Radiat Oncol Biol Phys       Date:  1976 Sep-Oct       Impact factor: 7.038

10.  [Proliferation rate and radiosensitivity. Bergonié's and Tribondeau's error].

Authors:  H P Beck-Bornholdt; H H Dubben; H Willers
Journal:  Strahlenther Onkol       Date:  1997-06       Impact factor: 4.033

View more
  1 in total

1.  Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.

Authors:  Wei Wu; Jessica L Klockow; Michael Zhang; Famyrah Lafortune; Edwin Chang; Linchun Jin; Yang Wu; Heike E Daldrup-Link
Journal:  Pharmacol Res       Date:  2021-07-21       Impact factor: 10.334

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.